Revenue from operations grew by 21% to ₹4,302 crore.
Apollo Hospitals Enterprise Ltd. (AHEL) reported consolidated net revenue for the fourth-quarter ended March rose 50% year-on-year to ₹146 crore.
The net revenue of Healthcare Services (HCS) rose 46% year-on-year to ₹257 crore. whereas Apollo Health & Lifestyle Ltd. (AHLL) posted a net lack of ₹23 crore. Apollo HealthCo. (AHL) logged a net lack of ₹89 crore, the hospital main mentioned in an announcement.
Apollo Hospitals Enterprise Ltd. Group CFO Krishnan Akhileswaran.
Revenue from operations grew by 21% to ₹4,302 crore of which HCS accounted for ₹2,195 crore, AHLL ₹309 crore and AHL ₹1,799 crore. The gross merchandise worth of Apollo 24/7 was ₹593 crore.
“The results of AHL Lare not comparable with the previous year as it included COVID related revenues , else like for like growth is 23%,” mentioned Group CFO Krishnan Akhileswaran. “The segment should get to 10% Operational EBITDA margins in FY24 and higher in the following year . Also Apollo HealthCo is on track for Q4 FY24 break-even. “
According to him, revenue from diagnostic business is expected to touch ₹500 crore this fiscal from ₹383 crore. Besides, the company is focused on improving the occupancy level in hospitals from 65% to 70% in the coming year which should further expand hospital margins
“We are on track to add 2000 beds over the next 4 years with a capital outlay of ₹3,000 crore which should predominantly come from internal accruals,” he added.
As on March, Apollo Hospitals had complete 70 hospitals with 9,957 working beds throughout the community (together with 562 beds in AHLL), out of which 14 hospitals had been new with 2,384 working beds.
The board declared remaining dividend of ₹9 per share.1
